RAFARM SA is a fully integrated pharmaceutical company established in 1974 and based in Attika, Greece. Our expertise is developing and producing complex pharmaceutical products, and our passion is making a positive and lasting impact in health. o Facilities: 15,000 sq.m. o Exports in 60 countries o 400 exported products / 15 formulations o 6 sterile products already marketed in the US o >1,100 approved product licenses o 10% investment on R&D (of net turnover in 2021) o 15% growth in total group turnover (2021 vs 2020) We are a well-established European manufacturer highly specialized in the research, development and supply of a wide range of complex pharmaceutical products with a specific focus on sterile forms, in particular ophthalmic products (solutions, suspensions and emulsions) and complex injectable products. Our integrated services include: • B2B: Licensing and Supply, Co-development, Distribution all over the world • B2C:Marketing and promotion in local markets (Greece and Cyprus) • Adaptive end-to-end CDMO Solutions We invest in difficult to make, complex pharmaceutical products and offer partnership opportunities in the fields of Ophthalmology, Chronic Kidney Disease and Pulmonary Arterial Hypertension. Why to partner with us?  Enriched options of complex pharmaceutical products with the highest quality standards  Flexible business partnerships worldwide  R&D extensive expertise on sterile forms and complex injectable products  Focus on time to market  Supplier reliability Why to join our team? In RAFARM, we are proud of our 600 talented people who are constantly demonstrating their remarkable expertise, their commitment and drive to develop, manufacture and market high quality complex drugs that improve the lives of patients in Greece and in more than 60 countries around the world. We value highly the well-being of our people and we strive to provide them with all the means for a balanced professional and personal life.